Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin
NEW YORK, NY, May 12, 2020 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) a leading biosciences and diagnostics company, […]